Digital rendering of BioSpring's expansion in Offenbach, Germany
December 21, 2022 02:41 PM EST
Pharma
Manufacturing

BioSpring in­vests €100M+ in­to new oligonu­cleotide API fa­cil­i­ties in Ger­many

Tyler Patchen

News Reporter

While the city of Of­fen­bach, Ger­many has been a his­tor­i­cal cen­ter of ma­chine-build­ing and leather­mak­ing, the Ger­man con­tract man­u­fac­tur­er BioSpring is look­ing to make it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times